Figure 1.

Selection criteria for patients enrolled for 6 and 12 months pre- and 6 and 12 months postswitch to once-monthly paliperidone palmitate (PP1M). AP = antipsychotic; PALI = paliperidone; RIS = risperidone. *The identification period for the 6-month cohort was defined as July 1, 2014, to September 30, 2017. ^†The identification period for the 12-month cohort was defined as January 1, 2015, to March 31, 2017. ^‡The index period was defined as the first dispensing of PP1M.